Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for Health-Reference-Cited by-同舟云学术

Challenges raised by the economic evaluation of CAR-T-cell therapies. The review by the French National Authority for Health

Published:2021-12 Issue:12 Volume:108 Page:1162-1169
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:en
Short-container-title:Bulletin du Cancer

Author:

Raimond Véronique^ORCID,Kaltenbach Emmanuelle^ORCID,Adam Christophe,Lazzarotto Sébastien,Le Galès Catherine^ORCID,Perrier Lionel^ORCID,Wittwer Jérôme

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference43 articles.

1. Trends in utilization of FDA expedited drug development and approval programs, 1987–2014: cohort study;Kesselheim;BMJ,2015

2. European Medicines Agency. Assessment report Kymriah 2018.

3. European Medicines Agency. Assessment report Yescarta 2018.

4. APM Health Europe - Gilead sets temporary price for CAR-T therapy Yescarta at €350,000 in France 12/28/2018 https://www.apmhealtheurope.com/samplestory/10/62005/gilead-sets-temporary-price-for-car-t-therapy-yescarta-at-e350%2C000-in-france.(accessed January 5, 2021).

5. Health APM Europe - Novartis seeking more «innovative payment models» for CAR-T Kymriah in Germany 04/12/2019 January;5:2021. https://www.apmhealtheurope.com/freestory/0/63585/novartis-seeking-more%2013innovative-payment-models%2013for-car-t-kymriah-in-germany.(accessed).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity;Annals of Hematology;2024-05-02

2. Les cellules CAR-T : prix, efficience et soutenabilité en France;Bulletin de l'Académie Nationale de Médecine;2024-05

3. Healthcare cost and utilization for chimeric antigen receptor (CAR) T‐cell therapy in the treatment of pediatric acute lymphoblastic leukemia: A commercial insurance claims database analysis;Cancer Reports;2024-01-13

4. Multidimensional Results and Reflections on CAR-T: The Italian Evidence;International Journal of Environmental Research and Public Health;2023-02-21